Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Nail disorders are often related to jobs like housework and manual labor, with cosmetic issues being the main concern, and are commonly caused by skin diseases like psoriasis.

The document describes skin diseases affecting the outer ear in dogs and cats, their spread to other body parts, and treatment options.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

People in palliative care often have skin problems due to their main illness or other health issues, and treatments focus on comfort and quality of life.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Growth factors and microneedle therapy increase hair density in women with hair loss.

Oral ulcers are common in SLE patients and often link to other symptoms.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

More research is needed to understand and manage angioedema in pregnant women with lupus.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

SLE and DM can coexist but are rare and need careful evaluation.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Belimumab effectively controls SLE disease activity and reduces steroid use.